CID 118873253

Darovasertib

Structural Information

Molecular Formula
C22H23F3N8O
SMILES
CC1(CCN(CC1)C2=C(N=CC=C2)NC(=O)C3=NC(=CN=C3N)C4=C(C=CC=N4)C(F)(F)F)N
InChI
InChI=1S/C22H23F3N8O/c1-21(27)6-10-33(11-7-21)15-5-3-9-29-19(15)32-20(34)17-18(26)30-12-14(31-17)16-13(22(23,24)25)4-2-8-28-16/h2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34)
InChIKey
XXJXHXJWQSCNPX-UHFFFAOYSA-N
Compound name
3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

4
References

743
Patents

472.1947 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 473.20198 198.2
[M+Na]+ 495.18392 206.6
[M+NH4]+ 490.22852 200.9
[M+K]+ 511.15786 201.4
[M-H]- 471.18742 198.9
[M+Na-2H]- 493.16937 205.9
[M]+ 472.19415 199.1
[M]- 472.19525 199.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe